AP-7 (drug)
AP-7 is a compound that acts as an antagonist for the NMDA receptor. It is a selective, competitive glutamate antagonist that is often used in scientific research.
Pharmacology[edit | edit source]
AP-7 is a competitive antagonist for the NMDA receptor, a type of ionotropic glutamate receptor. It acts by binding to the same site on the receptor as the natural ligand glutamate, preventing glutamate from activating the receptor.
Uses in Research[edit | edit source]
Due to its selective action on the NMDA receptor, AP-7 is often used in scientific research to study the role of this receptor in various processes. For example, it has been used to investigate the role of the NMDA receptor in neuroplasticity, learning and memory, and the development of tolerance and dependence to opioids.
Side Effects[edit | edit source]
As with any drug, AP-7 can have side effects. These can include neurotoxicity, which can lead to neuronal death. However, these side effects are generally only seen at high doses.
See Also[edit | edit source]
References[edit | edit source]
AP-7 (drug) Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD